Nephrocare Health Services investor meet on June 15-16
Nephrocare Health Services Limited will conduct a non-deal roadshow for analysts and institutional investors on June 15 and 16, 2026, in Mumbai. Hosted by Citi, the event will feature group and one-on-one interactions starting at 10:00 A.M. IST. The company confirmed that no unpublished price sensitive information will be shared during the meeting.

*this image is generated using AI for illustrative purposes only.
Nephrocare Health Services Limited has scheduled a non-deal roadshow for analysts and institutional investors on June 15 and 16, 2026, in Mumbai. The event, hosted by Citi, will facilitate group and one-on-one interactions starting at 10:00 A.M. IST onwards. The company clarified that discussions will be strictly based on publicly available information, with no intention to disclose any unpublished price sensitive information (UPSI).
The disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kishore Kathri, Company Secretary & Compliance Officer, signed the intimation on May 26, 2026. The company noted that the schedule remains subject to changes due to exigencies on the part of the host or the company.
Event Details
| Date & Time | Event | Host | Nature of Meeting | Place |
|---|---|---|---|---|
| 15th & 16th June, 2026 10:00 A.M. (IST) Onwards |
Non-Deal Roadshow | Citi | Group / 1*1 Meeting | Mumbai |
Historical Stock Returns for Nephrocare Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.33% | -6.86% | +13.41% | +28.40% | +28.40% | +28.40% |
What key performance indicators or strategic updates is Nephrocare likely to emphasize during the roadshow to attract institutional interest?
How might the market react to the roadshow in terms of stock volatility, given the strict adherence to publicly available information?
Could this roadsignal potential upcoming corporate actions, such as a fundraising round or M&A activity, despite being labeled as non-deal?


































